NCT00632840View on ClinicalTrials.gov

Pharmacological Regulation of Fat Transport in Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2007

Conditions
ObesityLipid DisordersHypertriglyceridemiaCardiovascular Disease
Interventions
DRUG

Atorvastatin and fenofibrate

atorvastatin (40mg/day) fenofibrate (200mg/day)

All Listed Sponsors
collaborator

National Heart Foundation, Australia

OTHER

lead

The University of Western Australia

OTHER

NCT00632840 - Pharmacological Regulation of Fat Transport in Metabolic Syndrome | Biotech Hunter | Biotech Hunter